The Promise of FTD Research Trials: What Should I Know About Current Drug Studies?
Register for this Webinar Today
The science of FTD is quickly evolving. While several years ago, there were no experimental treatments for FTD, there are now many medications being tested in clinical trials. Each trial has different eligibility criteria, type of intervention, length, and number of visits.
This Perspectives in FTD Research webinar, presented jointly by AFTD and the FTD Disorders Registry, aims to describe the current clinical trial landscape for FTD and how you can get involved.
This webinar will help you:
- Understand how FTD research has evolved and why there is a reason to be optimistic about future treatments.
- Identify the current industry-led clinical trials for FTD.
- Recognize what questions to ask to determine which trial(s) may be a good fit for you or your family.
- Learn the steps to take if you are interested in participating in a clinical trial.
This webinar will be recorded and archived on AFTD’s YouTube page.
Laura Mitic, PhD, is Chief Scientific Officer for the Bluefield Project to Cure FTD. She manages Bluefield’s efforts to translate scientific discoveries into therapeutics. She works closely with scientists in the Bluefield Research Consortium to identify and accelerate promising ideas and leads efforts to support the development of biomarkers and clinical endpoints for FTD. She meets regularly with academic and industry scientists to enable collaborative projects and oversees Bluefield’s communication strategy. Dr. Mitic earned an undergraduate degree in biology from Northwestern University and a Ph.D. in cell biology from Yale University. After completing postdoctoral studies in the genetics of aging at the University of California, San Francisco, she joined the Consortium for FTD Research (CFR) in 2009 and helped to establish the Bluefield Project in 2011.
Dianna Wheaton, PhD, joined the field of FTD research as Director of the FTD Disorders Registry in January 2016. She manages the daily operations of the Registry, working directly with persons diagnosed with FTD and their families, and leading outreach efforts to the lay and health professional communities. She assists clinicians, other researchers, and organizations interested in using the Registry to answer important research questions and to support clinical trials. Dr. Wheaton earned her Master of Science degree in Biology (Genetic Counseling) from the University of North Texas and her Ph.D. in Health Studies (Community/Population Health) from Texas Woman’s University. She has more than 20 years of clinical science research experience and genetic counseling for patients and at-risk family members.